Clinical Trial Update: An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating alirocumab for efficacy and safety in children and adolescents with homozygous familial hypercholesterolemia has completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• alirocumab (alirocumab)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2020-12-29